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Résumé 
Problématique : Le glutathion est une molécule clé de la défense antioxydante. Chez les 
enfants sous nutrition parentérale (NP), particulièrement les nouveau-nés, sa concentration 
tissulaire est anormalement basse. Puisque la capacité de synthèse de glutathion est 
adéquate, un déficit en cystéine, le substrat limitant, est soupçonnée. À cause de son 
instabilité en solution, la cystéine est peu présente en NP; la méthionine étant le précurseur 
endogène de cet acide aminé. L’activité de la méthionine adénosyltransférase (MAT), une 
enzyme essentielle à la transformation de la méthionine en cystéine, est facilement inhibée 
par l’oxydation. L’hypothèse : Le faible taux de glutathion chez les enfants sous NP est 
causé par l’inhibition de la MAT par les peroxydes contaminant ces solutions nutritives. 
Objectif: Mesurer l’impact d’une infusion de NP et de H2O2 sur l’activité hépatique de 
MAT en relation avec le niveau de glutathion. Méthode : Un cathéter est placé dans la 
jugulaire droite de cobayes de trois jours de vie. Quatre  groupes  sont comparés:1- Témoin 
(animaux aucune manipulation, sans cathéter)   2)-(animaux nourris normalement et le 
cathéter (noué)); 3) NP (animaux nourris exclusivement par voie intraveineuse (acides 
aminés + dextrose + lipides + vitamines + électrolytes), cette solution génère environ 400 
µM de peroxyde. 4) H2O2 (animaux nourris normalement et recevant via le cathéter 400 
µM de H2O2). Après quatre jours, le foie et le sang sont  prélevés pour la détermination du 
glutathion, potentiel redox et l’activité de MAT, glutathion peroxydase et glutathion 
reductase. Résultats : L’activité de MAT est plus faible dans les groupes NP et H2O2. Le 
potentiel redox  du foie et dans le sang est plus oxydé dans le groupe NP. Tandis que la 
concentration de GSSG du foie est plus élevée dans le groupe NP. Ainsi la concentration de 
GSH dans le sang  et foie est plus faible dans les NP et H2O2 Discussion: La relation entre 
l’inhibition de MAT et le stress oxydant observée dans le groupe NP pourrait bien 
expliquer la perturbation du système glutathion observée chez les nouveau-nés prématurés.  
 
Mots-clés : peroxydes, nouveau-né, glutathion peroxydase, glutathion réductase, 
méthionine adénosyl transférase, nutrition parentérale. 
  
ii
Abstract 
Introduction: The low glutathione level in premature newborns can partly explain the high 
incidence of complications associated with oxidative stress in this population. Since the 
synthetic activity of glutathione is mature, a lack of substrate, especially cysteine, is 
suspected. Methionine provided by their parenteral nutrition (PN) is the in vivo precursor of 
cysteine. Since, methionine adenosyltransferase (MAT), the first enzyme in methionine 
transformation, has redox sensitive cysteines, we hypothesize that peroxides contaminating 
PN inhibit the activity of MAT, leading to a lower availability of cysteine for glutathione 
synthesis. Methods:  At 3 days of life, guinea pigs a catheter fixed in jugular vein, the 
animals were separated in 4 groups: 1) Control: animals without any treatment and no 
catheter   2) sham: animals fed regular chow, a node closed their catheter; 3) PN: animals 
fed exclusively with parenteral nutrition (dextrose, amino acids, fat, vitamins) containing 
about 400 µM peroxides; 4) H2O2: animals fed regular chow and received continuously 400 
µM H2O2 through the catheter. Four days later, liver and blood were sampling for 
determination of reduced glutathione (GSH), oxidized glutathione (GSSG), redox potential 
and activities of MAT, glutathione peroxidase, and glutathione reductase. Results: MAT 
activity was lower in groups receiving PN or H2O2. Liver redox was more oxidized in PN 
group whereas blood redox was more oxidized in PN and H2O2.  Liver and blood GSH is 
lower in PN and H2O2. Liver GSSG was higher in PN. Conclusion:  The inhibition of 
MAT in the PN group could explain the disruption of the glutathione system observed in 
premature infants. Furthermore the impact of a lower activity of MAT on GSH level is 
observed in liver and blood. Suggesting that the hepatic synthesis of GSH is insufficient to 
maintain its own level of glutathione and sustain the rate of export. 
 
Keywords: Peroxides, newborn, glutathione peroxidase, reductase, methionine 
adenosyltransferase and parenteral nutrition. 
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1. Introduction 
Infants born before 28 weeks of gestation frequently require intravenous nutrition 
(parenteral nutrition) because of their immature gastrointestinal system. For these infants 
parenteral nutrition (PN) is the way to provide essential nutrients for growth and 
development. However, these nutrient solutions are contaminated by oxidizing molecules 
[1]. In addition to this oxidant load, newborn infants have immature antioxidant defenses 
including low glutathione levels [2], [3]. Therefore, neonates are at high risk of oxidative 
stress. 
Lee and Frank showed that the pulmonary activity of antioxidant enzymes such as 
superoxide dismutase, glutathione peroxidase and catalase increases as a function of 
gestational age in several animal species [4]. Scientists extrapolate this fact to the neonates. 
Furthermore, the key antioxidant molecule, namely glutathione, is low in premature infants 
[3].  The intracellular level of this molecule is essential. Glutathione modules, among others, 
the cellular redox potential which is an important regulator for metabolic functions [5]. The 
goal of my research is to explore new avenue explaining this abnormally low level of 
glutathione.  
In the next sections of the introduction, I will briefly discuss about the in vitro generation 
of oxidant molecules in PN solutions, the oxidative stress and its consequences in premature 
infants, and finally the in vivo generation of glutathione.  Then I will formulate my working 
hypothesis and the objectives of my graduated studies. 
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1.1.1.  Oxidative stress  
Oxidative stress derives from an abnormally high level of oxidative molecules in a 
cell or organ. Oxidative stress can be induced by an abnormally high production of 
oxidants, a low capacity of antioxidant defenses or both. Oxidants are produced as a 
consequence of ATP production in the mitochondria metabolism or by intracellular 
enzyme system or they can be initiated from external source such as inhaled oxygen and 
pollutants. An increase in intracellular levels of these oxidants will lead to damage to 
cellular lipids, proteins, and DNA consequently to impaired macromolecular function, 
cell function and finally can lead to cell death.  Thus oxidative stress plays an important 
role in development of several pathological complications. For example lung injuries, 
exposure to polluted air contaminating reactive oxygen species, mineral and dust can 
lead to airway inflammation, activate the inflammatory and apoptotic process. As show 
in Figure 1 under the normal condition there is a balance between the exposure to the 
oxidants and antioxidants leading to human body homeostasis. When the exposure to the 
oxidants is overload the cell is a situation of oxidative stress will lead to impaired 
cellular function as result the disease     
[6] ,[7].  
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Figure 1: Equilibrium redox balance 
GSH: reduced glutathione; GPx: glutathione peroxidase; GR: glutathione reductase ; SOD : 
superoxide dismutase   
 
 
1.1.2.  Parenteral nutrition 
Parenteral nutrition (PN) is a mixture of amino acids, dextrose, electrolytes, vitamins and 
lipids. Although PN is essential for the growth and development of the neonates, PN is also 
associated with undesirable effects caused by oxidant molecules generated in the solution 
[1]. Hence, PN represents a potential cause of several pathological complications observed 
in premature newborns that are associated with oxidative phenomena [8]. Since peroxides 
are an important player in our hypothesis, I will describe how these molecules can 
contaminate PN. 
Antioxidant defense 
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1.1.3.  PN as a source of oxidants  
 The generation of oxidant molecules in these solutions is caused by the interaction 
between reducers such as polyunsaturated fatty acids, several amino acids and vitamin C and 
a strong oxidant as dissolved oxygen. Several molecules derive from these interactions. 
Among them, are aldehydes and hydroperoxides [9] derived from lipid peroxidation and 
hydrogen peroxide (H2O2) from ascorbic acid [10]. Because PN contains a photo-sensitive 
compound, riboflavin, these reactions are catalyzed by ambient light [10]. Furthermore, 
these reactions contribute to the loss of fatty acids, amino acids and antioxidant vitamin such 
as ascorbate. This loss combined with the immaturity of antioxidant defences in premature 
newborns [11] is dramatic. Even perfect photo-protection of the solution reduces the 
concentration of peroxides by only half. However, this reduction is sufficient to induce 
metabolic changes in children [12]. Unfortunately, it is difficult to reach such photo-
protection in a clinical setting. Because light exposure during only a few minutes is 
sufficient to generate significant amounts of oxidant molecules in PN solution [10], the 
photo-protection must be initiated during the PN preparation in pharmacy without any 
exposure to the light until the bedside where the bag and delivery tubes must be fully 
covered [1]. 
1.1.4.  Consequences of oxidative stress in premature infants 
The infusion of PN to premature infants without adequate photo-protection is associated 
with several markers of oxidative stress such as high concentrations of peroxides and 
isoprostanes [13] in urine and an oxidized redox potential in whole blood [14],[15]. This 
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stress is associated with a greater incidence of several pathological complications observed 
in this population such as bronchopulmonary dysplasia [8],[16], [14], [17], [18].  This 
suggests that the antioxidants systems of premature infants, especially glutathione, are 
unable to fully scavenger the oxidant load associated with PN [13].  
 
1.1.5.  Reactive radicals and redox balance   
 During normal metabolism, the cell generates oxidizing molecules [19], [20]. Although 
these oxidant molecules can be derived from detoxification of xenobiotics, the main 
producer remains the oxidative phosphorylation in mitochondrion [21]. Because the standard 
redox potential of ½ O2: H2O is among the highest in biology (-0.82 V), oxygen is easily 
reduced in water through the various protein complexes of mitochondrion. During these 
processes, about 1 to 3% of O2 will be partially reduced [22], with generation of superoxide 
anion (
.
O2
-
)[23],[24]. Superoxide dismutase (SOD) converts two superoxide anions into 
hydrogen peroxide (H2O2) and oxygen[25],[26]. H2O2 can be reduced by two enzymes, 
catalase [27]or glutathione peroxidase (GPx), into O2 and H2O [28]. If not, H2O2 can react 
with Fe
2+
 forming the hydroxyl radical (
.
OH) via the Fenton reaction. This radical initiates 
lipid peroxidation that generates lipid peroxides, which can be eliminated by the action of 
GPx and of glutathione-S transferase (GST) [29],[30]. Therefore, peroxides from PN, mainly 
H2O2, or / and free radicals deriving from its one-electron reduction might be detoxified by 
the antioxidant defenses of the organism. 
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1.2.1. Antioxidant defenses 
An antioxidant is defined as a molecule or atom that gives an electron to the oxidant 
molecule or atom in order to reduce them. In general, the antioxidants are classified as 
endogenous, exogenous and as secondary. Superoxide dismutase (SOD), glutathione 
peroxidase (GPx), glutathione and catalase are the main representatives of the endogenous 
category  [31] whereas vitamin C and vitamin E as well as selenium and carotenoids are 
from exogenous sources (dietary antioxidant) [32]. Riboflavin (vitamin B2), zinc and 
manganese are considered as secondary antioxidants [33] for their participation in the 
activity of glutathione reductase and SOD [34]. For example: the action of SOD reduces the 
free radical anion superoxide in oxygen and hydrogen peroxide that will be reduced in water 
by catalase or GPx.  Catalase is present only in the peroxisome and, to a lesser extent, in 
mitochondria. In this organelle, GPx is more important than catalase for the reduction of 
hydrogen peroxide [35]. In addition, the absence of catalase in cytosol, except for the 
erythrocyte, underlines the importance of GPx.  
  Vitamin E and vitamin C are obtained from the diet. Vitamin E is a fat soluble 
vitamin that is incorporated into cell membranes where it protects them from the oxidative 
damage by scavenging free radicals [36], [37]  In this case, vitamin E becomes oxidized and 
inactive. Vitamin C (water soluble vitamin) is a strong reducing agent [38]. It participates in 
a variety of oxido-reductive reactions in the body such as the reduction of some metals such 
as Cu+
2
 and Fe+
3  
[39], allowing them to become available for the Fenton reaction, and the 
recycling of the oxidized form of vitamin E into its reduced and active form [40]. The 
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oxidized form of vitamin C can be returned to the reducing form by the action of the 
glutathione system [41].  
In addition to the recycling of vitamins C and E, glutathione works as a co-factor of 
several enzymes, especially glutathione peroxidase and glutathione-S-transferase. 
Glutathione is considered a key molecule in the antioxidant defenses of the organism.  
Hence, the next section is devoted to the glutathione. 
 
1.2.2. Glutathione  
1.2.3. Structure of glutathione 
 Glutathione is the tri-peptide γ-L-glutamyl-L-cysteinyl-glycine (GSH). It is 
omnipresent in the body and is especially concentrated in liver. Glutathione exists in two 
forms: reduced GSH and disulfide (GSSG) [42], frequently named oxidized form. GSH is 
the main form, existing in millimolar concentrations in most cells (liver 5–10 mM).  GSSG 
normally represents less than 1% of total glutathione concentration [43]. It is noted that the 
ratio GSSG/GSH may increase during oxidative stress. The concentration of both forms, 
GSH and GSSG, is important in the maintenance of the intracellular redox potential as 
discussed below (section 1.3.2).  
 
1.2.4. Glutathione synthesis 
           Since, GSH cannot freely cross the cellular membranes each cell must synthesize its 
own GSH [44]. This process requires two ATP per molecule of glutathione. The synthesis is 
a two-step catalyzed reaction [45]: 
 L-glutamate + L-cysteine + ATP → γ-glutamyl-L-cysteine + ADP + Pi  
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This first step of GSH synthesis is catalyzed by glutamate cysteine ligase, in presence of 
Mg
++
 and  is considered as a rate-limiting step [46]. Moreover, this step is regulated by 
availability of cysteine [47],[3].  Indeed, the intracellular level of cysteine is close to the km 
of the enzyme whereas the intracellular concentration of glutamate is far greater the Km. 
Hence, a little variation in the availability of cysteine will influence greatly the activity of 
this rate-limiting enzyme [48]. Cysteine is obtained from the diet, from protein or 
glutathione breakdown, and from endogenous methionine [49]. The availability of cysteine 
in newborns is particularly problematic [3], especially if they are nourished by a parenteral 
way (PN). Indeed, this solution contains low level of cysteine because it is oxidized in 
cystine that precipitates (low solubility) in these nutritive solutions [50]. In fact, the main 
source of cysteine for glutathione synthesis is derived from the transformation of methionine 
[51], [52]. The hypothesis (see section 2) of my research project is the transformation of 
methionine to cysteine is inhibited by oxidants molecules generated in parenteral nutrition.  
The second step of the glutathione synthesis is catalyzed by GSH synthase. In presence of 
K
+
 and Mg
++, the enzyme links the glycine to the dipeptide γ-glutamyl-L-cysteine. 
γ-glutamyl-L-cysteine + L-glycine + ATP → GSH + ADP + Pi 
 
In the following section, I will discuss to how the tissue concentration of GSH is regulated 
between organs.  
1.2.5. Inter-organ glutathione regulation  
For the in vivo regulation of the GSH,  some organs work as synthesizers of GSH, 
whereas others work as exporter [53]. The liver is considered both a synthesizer and 
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exporters of GSH. It establishes 90% of  the glutathione supply in blood via hepatic 
exportation [54], [55]. Indeed, the liver has a great level of glutathione synthesis for its own 
needs and for export via sinusoidal protein MRP3 [56] -glutamyltranspeptidase is an 
enzyme anchored in cell membranes with its catalytic site in the extracellular milieu. This 
-glutamyl moiety of glutathione on a second amino acid, 
forming two dipeptides (glutamyl-amino acid and cysteinylglycine). These dipeptides are 
absorbed by cells and hydrolysed in free amino acids. Free cysteine can be used for a de 
novo synthesis of GSH. Thus, we can conclude that the liver plays an important role in the 
whole body homeostasis of glutathione in all the other organs. 
 
1.3. Glutathione functions   
1.3.1. Maintenance of thiol status   
There are many redox couples in the cell that work together to maintains the intra 
cellular redox.  By this abundance (millimolar), one of the most important couple in the cell 
is GSSG/2GSH [5]. In fact, glutathione is considered the buffer of the intracellular redox 
potential.  
The redox potential can be estimated from the concentrations of both, GSH and 
GSSG, with the Nernst equation (Ehc = -240 -(59.1/2) log ([GSH] 2/ [GSSG]) mV at 25 oC  
pH 7. The redox potential Ehc is associated with the biological status of the cell. For 
example a redox potential of glutathione of -240 mV is associate with proliferating stage 
whereas a more oxidized potential such as -220 mV occurs during differentiation stage of 
cell and a more oxidized status, for instance -170 mV, induces apoptotic events [57]. This 
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fact can be explained by the following reaction in which thiol functions of several proteins 
can react with GSH or GSSG dependently of the redox potential [49]: 
Protein-SSG + GSH                protein-SH + GSSG 
                                           
This reaction regulates a variety of metabolic processes such as enzyme activity, transport 
activity and gene expression [58].  
 
1.3.2. Antioxidant function  
The first antioxidant property of glutathione is related to its participation in reduction 
of peroxides. For this purpose, it acts as a cofactor for GPx. Since during this reaction, GSH 
will be oxidized in its disulfure form (GSSG), the redox potential of the cell could be 
modified and consequently several metabolic pathways. Likely Proteins, in which thiols are 
important for their function, are subjects to be regulated by the redox potential of the cell.  
For instance, several phosphatases are regulated  this way. Therefore, pathways that use 
phosphorylation as regulation strategy are susceptible to be influenced by the redox 
potential. Here, MAT has sensitive thiols that are also influenced by the redox of the cell. 
Among other pathways that are regulated by the redox potential we find several enzymatic 
activities (as for the present study), active transports and gene expressions as mentioned in 
section 1.3.1. Hence, the redox potential could be maintained by the action of glutathione 
reductase (GR) that recycles GSSG in GSH as described below.  
 
1.3.3. Glutathione peroxidase (GPx)  
Glutathione peroxidase (GPx), an enzyme of which the catalytic action is dependent 
on the micronutrient selenium (Se), catalyzes the reduction of hydrogen peroxide (H2O2) or 
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organic peroxides to water and corresponding alcohols, respectively [59]. This reaction 
requires two molecules of glutathione (GSH) as reducing substrate [60]. Glutathione 
disulfide (GSSG) the oxidized glutathione is formed as the product of this reaction. The 
activity of this enzyme is tightly controlled since modification of its activity will lead to a 
alter intracellular concentration of hydrogen peroxide, an important modulator of the activity 
of several proteins [59] such as methionine adenosyltransferase, the targeted enzyme of my 
work.  
 
1.3.4. Glutathione reductase (GR) 
         Because an elevation of GSSG level in cells, following the action of GPx, will affect 
the cellular redox potential, which interferes with several metabolisms, normally GSSG is 
reduced back to GSH by the action of glutathione reductase (GR) in the presence of NADPH 
as electron donor [61],  [62]. In case where the action of GPx overpass the activity of GR, 
the accumulated GSSG will be actively exported to maintain the intracellular redox potential 
[63] . In this case, lower intracellular  level of GSH will affect the activity of GPx [64] 
because the normal level of GSH in cells is at the level of the Km of GPx. A lower level of 
GSH leads to a lower activity of GPx, allowing a higher level of H2O2 in cell [65]. To 
prevent this loss of glutathione, the cell stimulates its synthesis and it recycles the GSSG into 
GSH by GR. Hence, by maintaining the level of GSH, GR plays a critical role in the oxidant 
defense of the cell. GR contains two molecules of FAD per enzyme. FAD is derived from 
vitamin B2 and is why this vitamin is considered as a secondary antioxidant [66].  
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                                            Figure 2:  Redox cycle 
 
1.4. Methionine as source of cysteine  
          To maintain its pool of glutathione, premature newborns on PN (containing high level 
of peroxides) need cysteine. However, the instability of cysteine in solution limits its 
enrichment in PN. In addition, the cellular uptake of cysteine is immature in this population 
[48]. Therefore, the main source of cysteine for glutathione synthesis remains the 
transformation of methionine in cysteine (figure 3). Indeed, it is known that this essential 
amino acid that is primarily metabolized in the liver, serves as the endogenous source of 
cysteine and, consequently, for glutathione synthesis [67], [68]. 
 
Reduced glutathione 
2GSH  
Glutathione    peroxidase  
Selenium  Glutathione reductase  
Riboflavin (FAD) 
GSSG 
Oxidized glutathione  
Hydrogen  
peroxide  
H 2  O 2 
Water 
2H2O  
NADP  + 
NADPH+H+ 
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Methionine adenosyltransferase MAT
Methyl transferase 
S-adenosyl homocysteine
S-adenosyl methionine
ATP
Cysteine γ-glutamyl-cysteine GSH
Glutatione
synthase
Glutamate
cysteine ligase
α-Ketobutyrate
Homocysteine
cystathionine β synthase
Serine
Cystathionine
Trans-
Sulfuration
 
                         
                    Figure 3: endogenous conversion of methionine to cysteine   
 
As shown in Figure 3, the first enzyme involved in methionine metabolism is the methionine 
adenosyltransferase (MAT) that catalysis the conversion of methionine and ATP in S-
adenosylmethionine (SAM) [69], [70], [71], [72]. SAM is the principal methyl donor and 
participates in three key metabolic pathways in the liver: polyamine synthesis, 
transmethylation and transsulfuration [73],[74]. SAM by the action of methyltransferase is 
converted into S-adenosylhomocysteine (SAH), which is hydrolyzed to homocysteine and 
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adenosine through a reversible reaction catalyzed by SAH hydrolase. Then homocysteine 
exits through two pathways. First, it can be remethylated to form methionine by two 
enzymes: 1) methionine synthase is requires normal levels of folate and vitamin B12 [75], 
[76] and 2) betaine homocysteine methyltransferase, which requires betaine, a metabolite of 
choline [77], [78].  The second important metabolism of homocysteine is its conversion into 
cysteine via the transsulfuration pathway [79]. During this process, homocysteine is 
transformed into cystathionine by a reaction catalyzed by cystathionine β synthase (CBS). 
Finally free cysteine is released by vitamin B6-dependent enzyme cystathionase for 
glutathione synthesis [80], [68]. 
 
1.4.1. Methionine adenosyltransferase 
An inhibition of this enzyme will lead to the perturbation of metabolism needing 
methyl group, but also to a lower level of glutathione in subjects with a low exogenous 
source of cysteine [81], [82], [83], such as newborns on parenteral nutrition. What do we 
know about this enzyme? Three forms of this enzyme have been identified in mammalian 
tissues [84], [85]. MAT II, primarily expressed in extrahepatic tissues and fetal liver, is a 
heterotetramer formed of catalytic α2 and regulatory ß subunits. In adult liver, MAT exists 
as a tetramer (MAT I) and as a dimer (MAT III) of a single α1 subunit of 43.7 kDa [86], 
[87], [88]. I have focused my work on the liver. Consequently, the activities measured were 
from MAT I and III isomers.  
We assume that peroxides can inhibit the activity of MAT by two mechanisms. The 
first mechanism is by a direct effect on MAT cysteines. Knowing that   the catalytic site of 
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these enzymes has cysteinyl residues that are susceptible to oxidation [89], [81]. Avila et 
al have reported that, in vitro, MAT was inhibited by H2O2 [82].  
MAT –SH + H2O2  MAT-SOH (inactive) 
The second mechanism   is by modification of the redox potential. Therefore, levels of GSH 
and GSSG were important as show in these equations    
MAT-SOH + GSH  MAT-SSG (inactive) 
MAT-SSG + GSH   MAT-SH (active) + GSSG.    
Hence the peroxide had oxidized the cysteinyl residues of the enzyme.  This fact is the origin 
of our working hypothesis. 
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2.  Hypothesis 
We hypothesize that neonatal exposure to oxidant molecules in parenteral nutrition 
inhibits the hepatic activity of MAT, leading to a lower availability of cysteine for 
glutathione synthesis.  
 
 
2.1.  Objectives 
The general objective of this project is to understand why glutathione concentration is 
low in premature infants, and subsequently find new nutritional strategies to improve the 
level of this important molecule of antioxidant defenses.  
Two specific objectives were:  
1- Assess in an animal model of neonatal parenteral nutrition, newborn guinea pig, 
independently of prematurity, the impact of infusion of a standard parenteral 
nutrition on the hepatic activity of MAT, level of GSH and GSSG as well as the 
redox potential of glutathione. 
2-  Evaluate if the PN impact is associated with its H2O2 content, by comparing data 
from animals infused with H2O2, at same concentration that measured in PN, to 
those from animals receiving PN. 
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3.1. Materials  
I mentioned below the list of the products which I had used throughout the period of study.  
Ferrous chloride, potassium chloride, sodium chloride and xylenol orange were purchased 
from Agilent Technologies, Mississauga, ON, Canada and magnesium chloride from Anala 
R BDH Laboratory Suppliers, Poole, Angleterre.  Sodium hydroxide was obtained from 
American Chemicals, Montreal, QC, Canada and potassium hydroxide from Baker, 
Phillipsburg, NJ, USA. Xylazine was purchased from Bayer, Toronto, ON, Canada and 
methionine from Baxter, Mississauga, ON, Canada. Blood collection tubes (Vacutainer ® 
spray coated K2EDTA tubes) were obtained from BD, Oakville, ON, Canada and BioRad 
protein assay, power supply supply (Model 1000/500 Power Supply), AG 50W-X4 Resin 
cation exchange resin were from BioRad, Mississauga, ON, Canada. Tetra-acetic acid 
disodium, tris hydrochloride , bovine serum albumin (BSA), 4 - (2 – hydroxyethyl) -1 - 
piperazine ethane sulfonic acid (HEPES) were obtained from Boehringer Mannheim GmbH, 
Laval, QC, Canada. Guinea pigs animal model was purchased from Charles River St-
Constant, Montréal, QC, Canada ,  methanol from  Chemical products of ACP, Montreal, 
QC, Canada,  boric acid  from JT Baker Chemical Co, Polyurethane catheter from  
Phillipsburg NJ, USA , Luther Medical Product, Tustin, CA, USA, and  Intra lipid 20 
%,20% (Pharmacia Upjohn, Baie D’Urfé, QC, Canada),  multivitamins and amino acids 
from  Sandoz, Boucherville, Qc, Canada. Adenosine 5`-Triphosphate, Tetrasodium Salt, [2, 
8-3H] was obtained from PerkinElmer , reduced glutathione (GSH), oxidized 
glutathione(GSSG), glutathione reductase (GR), nicotinamide adenine dinucleotide 
phosphate (NADPH) from Roche Diagnostique, Montréal, QC, Canada, pediatric.  Ketamine 
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from Wyeth whereas xylazine from bayer health care Toronto, Ontario ,centrifuge tubes 
of 50 ml from  Sarstedt,  Montréal, QC, Canada, meta phosphoric acid, S-adenosyl-L-
methionine from Sigma-Aldrich Co, St-Louis, MO, USA and  filter papers from  Whatman, 
Florham Park, NJ, USA.  Finally all the solutions were prepared in pure water and all the 
other reagents were of analytical grade. 
  
3.2.Methods  
3.2.1. Animals  
At three days of life Hartley guinea pigs (Charles River Laboratories, 
St.Constant, Quebec,Canada) , were anesthetized by using ketamine (50mg/mL;0, 
18mL/100g) and xylazine (20mg/mL; 0,05mL/100g) in order to fix a catheter (Luther 
Medical Products, Tustin, CA) in jugular vein. The catheter was placed and externalized in 
the scapular region, with a branch connected to the infusion system.  
The studied intravenous solutions were infused continuously through the catheter at rate of 
22 mL / 100 g body weight / day. The solutions were changed daily.  
The research protocol was approved by the institutional committee of animal research and 
practices of the hospital Sainte-Justine built on the principles of the Canadian Council of 
animals. 
3.2.2. Experimental design   
The animals were classified into 4 groups  
1-  Control group: four animals of same age, without manipulation such as surgery, fed 
with regular laboratory food for guinea pigs. 
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2-  Sham group: three animals that were not fed through the catheter, the catheter was 
fixed and closed, but ate the laboratory food for Guinea pigs for the duration of the 
experiment. 
3-  PN: five animals fed exclusively with total parenteral nutrition (5% (w.v) dextrose + 
0.45% (w,v) NaCl + 4.8 g/kg/day amino acids + 3.8 g/kg/day Intralipid 20 and 1% (v,v) 
Multi12 pediatrics multivitamins  The PN solution used contained a similar composition to 
that one given to the children in neonatal care units. 
4- H2O2: Seven animals receiving 400 µM H2O2 through the catheter. These animals were 
fed with regular laboratory food for guinea pigs. 
Four days later, at seven days of age, animals were sacrificed for collection of liver and 
blood. The liver samples were removed, processed, aliquot and stored at -80
O
C until 
biochemical determinations. An aliquot of the blood was centrifuged to separate plasma 
from red blood cells. Both fractions and an aliquot of whole blood were and stored at -80
O
C 
until biochemical determinations.   
3.2.3.  The guinea pig as animal model 
Our newborn animal model was the guinea pig because, guinea pigs and humans are 
dependent on vitamin C [90], [91], a strong antioxidant molecule, they are unable to 
synthesize it and this is essential characteristic when we study mechanisms related to 
oxidative stress. Also it is an accessible animal model for the study of neonatal PN because 
at three days of life, the size of its body is sufficient (limit) for insertion of the smallest 
catheter of the world in its jugular  vein  , by this age, their glutathione development is not 
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complete [92], [93] , similarly to humans and weaning occurs early, by three days of life, 
this animal nourishes itself by itself [94 , 95, 96].  
The problematic of PN is observed mainly in premature newborns. Studies on the impact of 
PN in this population are difficult since no control exist, premature infants of the same 
gestational age without PN does not exist. By choosing a term newborn animal, we can 
separate the impact of PN from prematurity. Similarly to premature infants on PN, several 
markers of oxidative stress have been measured in this animal model on PN [97], [15]As 
observed with premature infants [17], the absence of photo-protection of PN induced a loss 
of alveoli [8], a characteristic feature of the bronchopulmonary dysplasia such observed in 
premature infants [14].   
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3.2.4.  Determination of peroxides  
Total peroxides were determined by following at 560 nm the generation of chromophore 
from the complex Fe
3+
-xylenol orange [98], [99]. The principle is based on the Fenton 
reaction in which ferrous ion (Fe
2+
) is oxidized in presence of H2O2 in its ferric form (Fe
3+
). 
Thus, diluted PN was mixed with reactive solution containing 22.5 mM H2SO4, 90 µM 
xylenol orange, 225 µM FeCl2, and 3.6 mM 2,6-di-tert-butyl-4-methylphenol in methanol. 
After 30 min of incubation, at the room temperature the solutions were centrifuged 5500 × g 
for 3 min). The absorbency of the supernatant was read at 560 nm. The results were 
expressed in µM. H2O2 was used for the external standard curve.  
 
3.2.5.   Protein determination  
 Protein was measured by Bradford method, the principle of this technique is a dye-
binding reaction to protein with a differential color change of a dye (Coommassie) occurs in 
response to the protein concentrations.  The absorbance was detected at 595nm. 
The pellets from different tissues were solubilized, with 1N NaOH   at 37 ° C for 2 hour.  
Addition dilution (1 / 250) was made; these dilutions were transferred to 
spectrophotometric cuvettes.  Bradford reagent previously diluted (1 / 5) with distal 
pure water was added.  Samples were incubated 10 minutes at room temperature. The 
absorbance values were compared to the curve of bovine serum albumin (BSA; 0 – 90 
pg/μL). 
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3.2.6.  GSH and GSSG levels 
Immediately after sampling, 200 μl of blood or 0.5 g of liver were mixed with 
respectively, 4 and 5 volumes of 5% (w/v) freshly prepared metaphosphoric acid. The blood 
sample was vortex for 10 seconds whereas the liver sample was homogenated on ice during 
20 seconds with Polytron (Biospec Products, Bartlesville, OK, USA). Thereafter, they were 
centrifugated for 1-3 min at 10000 RPM.  Supernatants (for glutathione determinations) and 
pellets (for protein determination) were separated and frozen at -80°C until the day of the 
assay.Reduced (GSH) and disulfide (GSSG) forms of glutathione were separated by 
capillary (75 μm×50 cm silica) electrophoresis (75 mM boric acid +25 mM Bis–Tris buffer, 
pH 8.4, 28°C, 18 kV) and were detected at 200 nm on a P/ACE MDQ system (Beckman 
Coulter). GSH and GSSG were used as external standard curves [95]. The redox potential 
was calculated by using the Nernst equation (25ºC, pH 7):  Ehc = -240-(59.1/2) log ([GSH]
 2
/ 
[GSSG]) mV. 
 
3.2.7.  Determination of glutathione reductase and peroxidase activity 
                    Tissue samples were homogenized in 9 times volume of (50 mM Tris-HCl, 0.1 
mM EDTA-Na2, pH 7.6) on ice. The homogenates were centrifuged 1 min at 10000 RPM. 
The supernatants were taken to determine the enzyme activities and protein levels.  
The determination of glutathione reductase (GR) activity is based on the following principle  
GSSG +   NADPH + H+ → 2 GSH + NADP+ 
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The activity of glutathione reductase is proportional to the disappearance of NADPH, 
which absorbs at 340 nm. The reaction is started by the addition of the biological sample in 
reactive milieu (50 mM Tris-HCl, 0.1 mM EDTA-Na2, 1 mM GSSG, and 0.1mM NADPH, 
pH 7.6). Slope of the drop of absorbance recorded during 10 minutes was quantified using 
the NADPH molar extinction coefficient of 6.22 mM
−1
cm
−1
. The activity was expressed 
as μmol NADPHoxidized/min/mg protein at 30°C.  
Glutathione peroxidase activity (GPx) was measured by mixing the supernatants with 
reactive solution (250 mM Tris,   0.1mM EDTA-Na2, 1 mM GSH, 1mM tert-butyl 
hydroperoxide, 4.8 U/mg GR, and 0.1mM NADPH, pH 7.6). Determination of the 
glutathione peroxidase activity is based on the following principle  
 2GSH + H2O2 → GSSG + 2H2O   
Then GR reduces the GSSG to complete the cycle: 
GSSG + NADPH + H+ → 2 GSH + NADP+ 
The decrease in NADPH absorbance measured at 340 nm during the oxidation of NADPH to 
NADP+ is indicative of GPx activity. Slope of the drop of absorbance recorded during 5 
minutes was quantified using the NADPH molar extinction coefficient of 6.22 mM
−1
cm
−1
. 
The activity was expressed as μmol NADPH oxidized/min/mg protein at 30C° [3].  
 
3.2.8. Determination of Methionine adenosyl transferase (MAT) 
                   Liver samples were homogenized on ice during 20 seconds with Polytron 
(Biospec Products, Bartlesville, OK, USA) in 4 volumes of (10 mM Tris/HCL, 0.3 M 
sucrose, 1 mM benzamidine, 0.1 mM phenylmethanesulfonylfluoride, and pH 7.5). The 
homogenate was centrifuged at 40000 g for 2h30 at 4 C
°
. The supernatants were taken for 
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determination of MAT activity and protein level. The supernatants were incubated at 37C
°
 
for 30 min with (75m M Tris/HCL, 250 mM KCl, 9 mM MgCl2, 60 µM methionine and 5 
mM [2-³H]ATP (1Ci/mol), pH 7.8). The reaction was stopped by adding 3 ml of cold water 
and immediately applied onto the cation exchanger Dowex AG5OW columns (0.5 ml) that 
was previously prepared and balanced with water, adjusted pH at 7 with NaOH. The 
chromatography was made at room temperature. Subsequently, the column was washed with 
20 ml water to get rid of the unused radioactive substrate. The H
3
-S-adenosyl methionine 
was eluted by using 4 ml of 3M NH4OH. The radioactivity of this fraction was measured by 
liquid scintillation by a beta counter (Beckman Co, Fullerton, CA, USA). The activity was 
expressed as nmol-S-adenosyl methionine formed/min/mg protein at 37°C [81], [86], [100].  
 
3.2.9. Statistical analysis  
Data were presented as mean ± s.e.m. and were orthogonally compared by Two way 
ANOVA as follows: 1) Control vs. Sham that will inform on the impact of surgery (we 
expected to find no rejection of null hypothesis); 2) PN vs. H2O2 that will inform on the 
impact of intravenous nutrition vs. per os alimentation (we expected to find no rejection of 
null hypothesis); 3) [control – sham] vs. [PN – H2O2] that will inform on the impact of 
intravenous infusion of peroxides (we expect to find a rejection of null hypothesis). 
Verification of homoscedasticity was tested by the Bartlett’s   Chi square test χ2, the level of 
significance was set at p <0.05. 
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4.  Results 
 4.1. Hepatic methionine adenosyl transferase (MAT) 
MAT activity was lower (p < 0.01) in groups received PN or H2O2 as shown in Figure 4. 
There was no difference between PN and H2O2 or between control and sham group 
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Figure 4:  Hepatic activity of MAT as a function of treatments. 
Control: animals without any manipulation; Sham: animals with catheter in jugular, without 
infusion, enterally fed; PN: animals fed exclusively with parenteral nutrition (PN); H2O2: 
animals received intravenous solution containing 400 µM H2O2, enterally fed. The activity 
of MAT was lower in groups infused with solution containing peroxides (PN and H2O2).  
Mean  s.e.m.; n.s.: no statistical difference; **: p<0.01. 
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4.2. Hepatic glutathione 
         The statistical analysis shown in Figure 5 the redox potential of glutathione was higher 
(more oxidized) in PN group (p<0.01) than in H2O2 group whereas the impact of surgery 
(control versus Sham) was without impact.  The level of GSH Figure 6, A was low in 
animals that received PN or H2O2 whereas GSSG levels Figure 6, B were higher (p<0.01) in 
PN group compared to H2O2 group. 
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Figure 5:  Hepatic redox potential as a function of treatments. 
Control: animals without any manipulation; Sham: animals with catheter in jugular, without 
infusion, enterally fed; PN: animals fed exclusively with parenteral nutrition (PN); H2O2: 
animals received intravenous solution containing 400 µM H2O2, enterally fed. The hepatic 
redox was more oxidized in groups infused with solution containing peroxides (PN and 
H2O2).  Mean  s.e.m.; n.s.: no statistical difference; **: p<0.01.  
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Figure 6:  Hepatic GSH and GSSG levels as a function of treatments. Control: animals 
without any manipulation; Sham: animals with catheter in jugular, without infusion, 
enterally fed; PN: animals fed exclusively with parenteral nutrition (PN); H2O2: animals 
received intravenous solution containing 400 µM H2O2, enterally fed. The hepatic GSH level 
(A) was lower in groups infused with solution containing peroxides (PN and H2O2) whereas 
the hepatic GSSG (B) was higher in PN.  Mean  s.e.m.; n.s.: no statistical difference; *: 
p<0.05, **: p<0.01.   
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4.3 Blood glutathione 
       The statistical analysis shown in Figure 7 the redox potential of glutathione in blood was 
higher (more oxidized) in PN and H2O2 groups.  There was no difference between PN and 
H2O2 groups or between control and sham groups. The level of GSH Figure 8, A was low in 
animals infused with PN or H2O2 whereas GSSG level Figure 8, A was higher (p<0.01) in 
PN group compared to H2O2 group. 
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Figure 7: Blood redox as a function of treatments. Control: animals without any 
manipulation; Sham: animals with catheter in jugular, without infusion, enterally fed; PN: 
animals fed exclusively with parenteral nutrition (PN); H2O2: animals received intravenous 
solution containing 400 µM H2O2, enterally fed. The redox in the blood was lower in groups 
infused with solution containing peroxides (PN and H2O2).  Mean  s.e.m; n.s.: no statistical 
difference; **: p<0.01.   
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Figure 8:  Blood GSH and GSSG levels as a function of treatments. Control: animals 
without any manipulation; Sham: animals with catheter in jugular, without infusion, 
enterally fed; PN: animals fed exclusively with parenteral nutrition (PN); H2O2: animals 
received intravenous solution containing 400 µM H2O2, enterally fed. The blood GSH (A) 
was lower in groups infused with solution containing peroxides (PN and H2O2) whereas the 
blood GSSG (B) was lower in animals infused with H2O2.  Mean  s.e.m.; n.s.: no statistical 
difference; **: p<0.01 *: p<0.05.   
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4.4. Hepatic and erythrocyte glutathione peroxidase activity. 
       Glutathione peroxidase activity was higher (p < 0.01) in liver from animals infused with 
H2O2 as shown in figure (9, A). In contrast, in blood, the activity of GPx was lower (p< 0.01) 
in the group received peroxides (PN and H2O2) Figure 9. In both tissues, there was no 
difference between control and sham groups. 
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Figure 9:  Hepatic and erythrocyte GPx activity as a function of treatments.  
 Control: animals without any manipulation; Sham: animals with catheter in jugular, without 
infusion, enterally fed; PN: animals fed exclusively with parenteral nutrition (PN); H2O2: 
animals received intravenous solution containing 400 µM H2O2, enterally fed. The hepatic 
GPx activity (A) was higher in group H2O2. Whereas GPx activity in the red blood cells (B) 
was lower in groups received peroxides PN, H2O2.  Mean  s.e.m.; n.s.: no statistical 
difference; **: p<0.01, **: p<0.01.    
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4.5. Hepatic and erythrocyte glutathione reductase activity. 
          Compared to PN groups, the activity of glutathione reductase were higher (p < 0.05) in 
liver and erythrocytes from group H2O2 as shown in Figures 10 There was no difference 
between control and sham groups.  
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Figure 10:  Hepatic and erythrocyte GR activity as a function of treatments. Control: 
animals without any manipulation; Sham: animals with catheter in jugular, without infusion, 
enterally fed; PN: animals fed exclusively with parenteral nutrition (PN); H2O2: animals 
received intravenous solution containing 400 µM H2O2, enterally fed. The activity of hepatic 
GR (A) was lower in groups infused with peroxide H2O2. While the activity of GR in the red 
blood cells (B) was lower in PN group Mean  s.e.m.; n.s.: no statistical difference; **: 
p<0.01, *: p<0.05.   
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4.6. Association between the hepatic MAT activity and hepatic GSH level  
Hepatic MAT activity was correlated significantly and positively (r
2
 = 0.41, p <0.01) with 
hepatic GSH level as in Figure 11. 
 
 
 
 
Figure 11: Hepatic GSH level in function of hepatic MAT activity. The hepatic GSH 
level was positively correlated (r
2
 = 0.41, p <0.01) with hepatic MAT activity. 
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5. Discussion 
This study tested the hypothesis that peroxides contaminating PN inhibit the activity 
of MAT, leading to a lower availability of cysteine for glutathione synthesis.  Our data 
demonstrated that indeed, the PN during four days inhibits strongly the activity of hepatic 
MAT. This inhibition is reproduced by an infusion of a solution containing a concentration 
of H2O2 similar to that measured in PN.  In addition, we identified an association between 
the inhibition of MAT activity and GSH level. This is the first study demonstrating this new 
avenue (inhibition in transformation of the methionine to cysteine) explaining the 
abnormally low level of glutathione in premature infants receiving PN.  
Because PN contains oxidant molecules such as peroxides the inhibition of MAT can 
result from a direct effect of peroxides on active thiols of the enzyme or from a lower 
recycling of the enzyme that is dependent on the redox potential which is oxidized in 
animals on PN. Indeed, the in vivo total activity of MAT is dependent of the equilibrium 
between its active (MAT-SH) and inactive (MAT-SOH) form. Peroxides react with thiol to 
generate the inactive form (MAT-SOH) whereas the redox status favors the reduction of 
MAT–SOH in MAT–SH. The discrepancy between hepatic redox potential observed in 
animals infused with PN or H2O2 suggests that the inhibition of MAT did not result from a 
more oxidized hepatic redox. 
           With inhibition of MAT following the infusion of peroxides, we expected to observe 
a more oxidized redox potential in PN and H2O2 groups. Indeed, the lower level of GSH in 
liver and in blood contributes to a more oxidized redox status. On the other side, a greater 
level of GSSG also induces a more oxidized redox. However the accumulation of GSSG was 
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observed only in liver of animals received PN. This last observation is sufficient to 
explain the more oxidized redox potential calculated only in PN group. Interestingly, the 
infusion of H2O2 has induced a lower level of both GSH and GSSG. Hence, the redox 
potential is maintained in this group. The difference between PN and H2O2 on GSSG 
suggests that PN exerts an oxidizing activity which is not only related to H2O2. This effect of 
PN may be related to others oxidants molecules such as ascorbyperoxide, lipid peroxides and 
4-hydroxynonenal that also contaminate the solution of PN [101], [9] , [102]. Alternatively, 
the explanation can come from the fact that the infusion of H2O2 induces free radicals [103] 
which are known to activate transcription factors such as NF-E2-related factor 2 (Nrf2) 
[104], [105].  This factor plays a physiological role in the regulation of oxidative stress by 
activation of gene transcription for GPx and GR [106]. This is supported by the higher 
hepatic activities of both enzymes observed only in the H2O2 group. These two enzymes 
play an important role on the redox potential, especially GR that recycles GSSG in GSH. 
This fact can explain the low GSSG in animals infused H2O2. The absence of modification 
of activity of these two enzymes in PN group can be explained by the presence of the free 
radical scavenging vitamin C and vitamin E [107]. The activation of this transcription factor 
is not possible in red blood cell because the absence of nucleus. The activities of both 
enzymes were not increased in this tissue.  On the contrary, we observed a lower activity of 
GPx in animals infused with solutions containing peroxides. It is known that peroxides in 
high concentration inhibit GPx activity [108], [109].  
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The impact of a lower activity of MAT on GSH level is also observed in blood. 
The level of glutathione in extrahepatic tissues is dependent of the level of GSH exported by 
the liver. This extracellular level of GSH serves as a source of essential cysteine for GSH 
synthesis.  Hence, results from blood highlight that the hepatic synthesis of GSH is 
insufficient to maintain its own level of glutathione and sustain the rate of export into the 
plasma.   
 A major difference between the PN and H2O2 groups in regards of the glutathione 
level resides in the fact that animals infused with PN did not receive cysteine from their 
nutrition whereas animals infused with H2O2 fed regular chow that contains cysteine [95]. 
Given that the availability of cysteine is a rate-limiting step in the synthesis of GSH, the 
comparison of both groups informs also on the impact of the mode of nutrition. We can 
expect that the presence of cysteine in enteral food of H2O2 group enables them to sustain 
GSH synthesis and consequently its level in liver and blood. Our results show that this 
source of cysteine did not correct for the impact of the inhibition of MAT on the glutathione 
level. This observation could explain the absence of impact of cysteine supplementation on 
glutathione level in premature infants [50]. Therefore, these data suggest that, in neonates, 
endogenous conversion of methionine to cysteine is more important for glutathione synthesis 
than exogenous source of cysteine. 
                The impact of abnormally low MAT activity can also explain, at least partially, 
two major complications observed in premature infants: cholestasis and frequent blood 
transfusion. A lower level of SAM, following inhibition of MAT, could induce hepatic 
cholestasis. Indeed, several studies reported that SAM prevents the development of 
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cholestasis by maintaining normal liver membrane Na+-K+-ATPase activity through 
preservation of the membrane lipid environment [110, 111, 112]. In addition, cholestasis 
associated with PN can also be explained by a low glutathione production following a low 
level of SAM; glutathione favors bile formation [113, 114, 115]. The second impact of our 
conclusion is related to the oxidative stress of red blood cells (more oxidized redox potential, 
lower level of GSH, lower activity of an enzyme detoxifying peroxides (GPx). Oxidative 
stress is a major cause of aging of these cells, shortening their lifespan [116] , [117]. Hence, 
inhibition of MAT may also be responsible for the high number of transfusions required by 
premature infants.  
 In summary, the results of this study support our hypothesis that the inhibition of 
MAT in the PN group could contribute to the disruption of the glutathione system observed 
in premature infants. Moreover this inhibition appears to be caused by H2O2 contaminating 
PN. The impact of a lower activity of MAT on GSH level is observed in liver and blood. 
Knowing that the liver exports actively GSH for the benefit of other organs, results suggest 
that the hepatic synthesis of GSH is insufficient to maintain its own level of glutathione and 
sustain the rate of export. The differences between PN and H2O2 on GSSG levels suggesting 
that PN exerts another oxidizing activity 
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Figure 11: summary for the experimental design and the obtained results  
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6. Limits of this study  
 PN is a mode of nutrition frequently used in neonates born before 28 weeks of 
gestation. The investigation of the impact of PN in this population is difficult because 
control groups of premature newborns without PN cannot exist. The use of newborn animals 
born at term enabled us to study the impact of PN during a neonatal period independently of 
the prematurity. Therefore, we need to take caution in the extrapolation of data collected 
with this animal model to human premature newborn.  However, we could expect to find 
similar impacts in premature infants as observed with the animals. Unfortunately the absence 
of control groups of premature newborns without PN thus, it is possible that the prematurity, 
itself, causes the elevation of all the of oxidative stress markers. 
 Additionally all the animals in our experiment are males alternatively, Lavoie has 
been shown that in cells extracted from endotracheal aspirates from the baby girl and boy the 
increased curve of glutathione levels in function of the gestational age is slower in boys.  
These results suggesting that the baby girl is potentially better protected against an oxidative 
stress than boy. As I mentioned in section 1.1.4 (consequences of oxidative stress in 
premature infants) oxidative stress is associated with a greater incidence of several 
pathological complications observed in this population such as bronchopulmonary dysplasia. 
Knowing that sex is an important determinant of the incidence of this disease among 
premature infants, the boys are much higher incidence to this disease. In addition the recent 
published results demonstrate there is a correlation between this disease and the redox 
potential of the glutathione.  Thus this the main reason for choosing the animals male to 
achieve our hypothesis with the population that more vulnerable for oxidative stress.  
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Given that the level of the glutathione is different between baby girls and baby boys as 
well as their vulnerability to the oxidative stress differs according to the sex. So, in my 
opinion, it would be interesting to repeat the experiments with female animals in order to 
separate the effect of sex. 
7. Future work  
Further studies are needed to investigate the impact of PN or peroxides on the 
activation of Nrf2 which control the gene transcription of Glutamate-cysteine ligase, the 
rate-limiting step in the synthesis of glutathione (GSH). In addition, the determination of 
cysteine level in the liver and blood. Since activity of MAT is sensitive to the redox state of 
their cysteine residues; its activity is inhibited by peroxides. It will be interestingly to 
challenge the hypothesis of the protective effect of the reducing agents such as hexapeptides 
which derived from human milk or Dithiothreitol on the hepatic MAT activity.  Supporting 
this hypothesis our lab team demonstrated that by the addition of hexapeptides which 
derived from human milk limit the generation of peroxides in PN moreover correct the redox 
potential and prevent PN-induced hepatic oxidative stress. Moreover it will be important to 
apply these studies for the neonates in order to decrease the incidence of all the 
complications which related to oxidative stress for this population by increase the production 
of GSH.  
As consequence, the hepatic redox potential of glutathione switches to a more 
oxidized status, which could be a first factor leading to development of several pathological 
complications of neonates on PN. An important possibility in the clinic the blood status 
could be a representative reflection of liver disturbance. 
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8. Conclusion  
Oxidative stress plays a potential role of several medical complications in premature 
infants such as bronchopulmonary dysplasia. This stress is associated with their treatment 
PN and their low antioxidant defense, including glutathione.  Our results demonstrated that 
peroxides contaminating PN inhibit the activity of MAT, leading to a lower availability of 
cysteine for glutathione synthesis.  Thus, with the increasing number of premature births in 
Canada, our results underline the urgency to develop safer intravenous nutritive solutions, 
which do not generate unwanted molecules such as peroxides. With such nutritive solution, 
it would be possible to improve the antioxidant defense of neonates and consequently 
diminish the incidence of pathological complications related to oxidative stress. 
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